CVA Family Office’s Kindred Biosciences, Inc. KIN Stock Holding History

CVA Family Office’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,500	Closed	-$11K	–	930
2021 Q3	$11K	Buy	+2,500	New	+$23K	0.01%	292
2020 Q4	–	Sell	-2,500	Closed	-$11K	–	381
2020 Q3	$11K	Hold	2,500	–	–	0.01%	292
2020 Q2	$11K	Buy	2,500 +500	+25%	+$2.23K	0.01%	256
2020 Q1	$8K	Buy	+2,000	New	+$17K	0.01%	253

CVA Family Office's KIN Position: Q4 2021 in Review

CVA Family Office sold out of Kindred Biosciences, Inc. (KIN) in Q4 2021, closing a stake of 2,500 shares — an estimated $11K sold.

CVA Family Office first reported a position in KIN in Q1 2020 and held it in 4 quarters. The position peaked at $11K in Q3 2021. 0 funds tracked by Wall St. Rank hold KIN as of Q4 2021.

CVA Family Office reported no remaining Kindred Biosciences, Inc. position as of Q4 2021 after selling out during the quarter.
CVA Family Office sold 2,500 Kindred Biosciences, Inc. shares in Q4 2021, an estimated $11K.
CVA Family Office first reported a position in Kindred Biosciences, Inc. in Q1 2020 and held it in 4 quarters.
CVA Family Office's Kindred Biosciences, Inc. position peaked at $11K in Q3 2021.
0 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q4 2021.

Based on CVA Family Office's 13F filing for Q4 2021, filed 25 Jan 2022.